Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Handheld Device Uses Light Energy in Treatments

By HospiMedica International staff writers
Posted on 24 Jun 2018
A novel device delivers blue, red, and near-infrared (NIR) light energy to safely address a wide variety of musculoskeletal and dermatological conditions.

The BioPhotas (Anaheim, CA, USA) Celluma POD light therapy device emits light in a range of wavelengths, which are absorbed by molecules participating in diverse cellular processes. More...
The result is decreased inflammation, increased microcirculation, and an increase in collagen production, all speeding cellular healing. The Celluma POD is designed to treat periorbital and full-face wrinkles, acne, muscle and joint pain, muscle and joint stiffness, muscle tissue tension, muscle spasm, arthritis, and compromised local blood circulation.

The photonic energy is delivered via light emitting diode (LED) technology, which stimulates the basic energy process in the mitochondria of each cell, particularly under NIR light. In addition, according to the U.S. National Aeronautics and Space Administration (NASA), DNA synthesis in fibroblasts and muscle cells is quadrupled when exposed to LED light. The pod-shaped handheld device can be applied almost anywhere on the body, or even used in a hands-free form in certain treatments areas.

“Leveraging the clinically-proven performance of our LED panel devices, we are introducing a handheld LED device that is different from any other device available on the market today,” said Patrick Johnson, President and CEO of BioPhotas. “Typically, handheld light therapy devices are configured for a single purpose, like treating pain or acne. However, the Celluma POD has three separate programs all in a single device for treating acne, wrinkles, and musculoskeletal pain in a targeted fashion.”

Light therapy consists of exposure to daylight or to specific wavelengths of using polychromatic polarized light, lasers, LEDs, fluorescent lamps, dichroic lamps or very bright, full-spectrum light. The light is administered for a prescribed amount of time and, in some cases, at a specific time of day.

Related Links:
BioPhotas


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.